title: Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function.
abstract: Pneumococcal vaccination is a commonly used technique for assessing the humoral immune status of a patient suspected of having immunodeficiency. Interpretation of what constitutes an adequate response, however, can be challenging. This is due to the complexity of the data generated from serotype-specific assays, historical variations in the assays used to measure pneumococcal antibodies, and varying recommendations on the relevant cut points that define response. In this review, we summarize the historical evolution of assays used for this purpose and discuss the analytical considerations that have influenced published data. We also examine current clinical recommendations for defining an adequate response to vaccination, with a particular focus on the interpretation of serotype-specific data generated by multiplex assays.
authors.affiliation: Robert J. Tomsich Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA dalyt@ccf.org.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Daly
authors.affiliation: ARUP Laboratories, Salt Lake City, Utah, USA Departments of Pathology, Pediatrics, and Medicine, University of Utah, Salt Lake City, Utah, USA.
authors.forename: Harry R
authors.initials: HR
authors.lastname: Hill
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood*; D019411:Clinical Laboratory Techniques / Q000379:methods* / Q000592:standards*; D006801:Humans; D007107:Immune System / Q000502:physiology*; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000276:immunology*; D013296:Streptococcus pneumoniae / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D022242:Pneumococcal Vaccines